Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SCHEDULE – M – Revised

How Schedule M (Revised) Guidelines Address Contamination Risks in Pharma Manufacturing

Posted on December 15, 2024 By digi

How Schedule M (Revised) Guidelines Address Contamination Risks in Pharma Manufacturing Addressing Contamination Risks in Pharma Manufacturing with Schedule M (Revised) Guidelines Introduction to Contamination Risks in Pharmaceutical Manufacturing Pharmaceutical manufacturing demands the highest levels of cleanliness and control to ensure product safety and efficacy. Contamination, whether microbial, chemical, or cross-contamination, poses a significant risk…

Read More “How Schedule M (Revised) Guidelines Address Contamination Risks in Pharma Manufacturing” »

SCHEDULE - M - Revised

How to Incorporate Schedule M (Revised) GMP into Your Pharmaceutical QMS

Posted on December 16, 2024 By digi

How to Incorporate Schedule M (Revised) GMP into Your Pharmaceutical QMS Integrating Schedule M (Revised) GMP Guidelines into Your Pharmaceutical Quality Management System Introduction to Schedule M (Revised) and Quality Management Systems (QMS) The pharmaceutical industry is bound by stringent regulations to ensure product safety, efficacy, and quality. Schedule M (Revised), under the Drugs and…

Read More “How to Incorporate Schedule M (Revised) GMP into Your Pharmaceutical QMS” »

SCHEDULE - M - Revised

The Role of Documentation and Record Keeping in Schedule M (Revised) Compliance

Posted on December 16, 2024 By digi

The Role of Documentation and Record Keeping in Schedule M (Revised) Compliance Importance of Documentation and Record Keeping in Schedule M (Revised) Compliance Introduction to Documentation and Record Keeping in Pharma GMP In pharmaceutical manufacturing, maintaining accurate and detailed records is not just a regulatory requirement but a cornerstone of Good Manufacturing Practices (GMP). Under…

Read More “The Role of Documentation and Record Keeping in Schedule M (Revised) Compliance” »

SCHEDULE - M - Revised

Schedule M (Revised) GMP Requirements for Pharmaceutical Packaging and Labeling

Posted on December 17, 2024 By digi

Schedule M (Revised) GMP Requirements for Pharmaceutical Packaging and Labeling Understanding Schedule M (Revised) GMP Guidelines for Pharmaceutical Packaging and Labeling Introduction to Packaging and Labeling in Pharma GMP Packaging and labeling are critical components of pharmaceutical manufacturing, ensuring product integrity, patient safety, and regulatory compliance. Under Schedule M (Revised), the Drugs and Cosmetics Act,…

Read More “Schedule M (Revised) GMP Requirements for Pharmaceutical Packaging and Labeling” »

SCHEDULE - M - Revised

Common Schedule M (Revised) GMP Violations and How to Avoid Them

Posted on December 18, 2024 By digi

Common Schedule M (Revised) GMP Violations and How to Avoid Them Identifying and Avoiding Common Schedule M (Revised) GMP Violations Introduction to Schedule M (Revised) GMP Compliance Schedule M (Revised), under the Drugs and Cosmetics Act, 1940, sets forth stringent Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of pharmaceutical products. Compliance…

Read More “Common Schedule M (Revised) GMP Violations and How to Avoid Them” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Helps with Drug Stability and Shelf Life

Posted on December 18, 2024 By digi

How Schedule M (Revised) GMP Helps with Drug Stability and Shelf Life Ensuring Drug Stability and Shelf Life Through Schedule M (Revised) GMP Guidelines Introduction to Drug Stability and Shelf Life Drug stability and shelf life are critical parameters in pharmaceutical manufacturing. They ensure that a drug maintains its intended efficacy, safety, and quality throughout…

Read More “How Schedule M (Revised) GMP Helps with Drug Stability and Shelf Life” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India

Posted on December 19, 2024 By digi

How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India The Impact of Schedule M (Revised) GMP Standards on India’s Pharmaceutical Supply Chain Introduction to Schedule M (Revised) and the Pharmaceutical Supply Chain The pharmaceutical supply chain is a complex network encompassing raw material procurement, manufacturing, storage, distribution, and delivery to end-users….

Read More “How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India” »

SCHEDULE - M - Revised

How to Train Your Staff to Meet Schedule M (Revised) GMP Requirements

Posted on December 20, 2024 By digi

How to Train Your Staff to Meet Schedule M (Revised) GMP Requirements Effective Training Strategies to Ensure Compliance with Schedule M (Revised) GMP Standards Introduction to Staff Training and Schedule M (Revised) The successful implementation of Schedule M (Revised) Good Manufacturing Practices (GMP) relies heavily on a well-trained workforce. Staff at all levels of a…

Read More “How to Train Your Staff to Meet Schedule M (Revised) GMP Requirements” »

SCHEDULE - M - Revised

The Role of CAPA in Schedule M (Revised) GMP Compliance

Posted on December 20, 2024 By digi

The Role of CAPA in Schedule M (Revised) GMP Compliance Understanding the Role of CAPA in Ensuring Schedule M (Revised) GMP Compliance Introduction to CAPA and Schedule M (Revised) GMP In pharmaceutical manufacturing, maintaining product quality and regulatory compliance is paramount. Corrective and Preventive Actions (CAPA) is a critical component of Good Manufacturing Practices (GMP)…

Read More “The Role of CAPA in Schedule M (Revised) GMP Compliance” »

SCHEDULE - M - Revised

Schedule M (Revised) GMP Guidelines for Clinical Trials and Investigational Medicinal Products (IMPs)

Posted on December 21, 2024 By digi

Schedule M (Revised) GMP Guidelines for Clinical Trials and Investigational Medicinal Products (IMPs) Comprehensive Schedule M (Revised) GMP Guidelines for Clinical Trials and Investigational Medicinal Products Introduction to Clinical Trials and Investigational Medicinal Products Clinical trials are a critical phase in the development of new pharmaceutical products, requiring strict adherence to regulatory standards to ensure…

Read More “Schedule M (Revised) GMP Guidelines for Clinical Trials and Investigational Medicinal Products (IMPs)” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 2 3 … 5 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme